tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Zhuang, 4 are a BUY (100%).
Analyst Jason Zhuang, currently employed at LEERINK, carries an average stock price target met ratio of 50% that have a potential upside of 60.25% achieved within 463 days.
Jason Zhuang’s has documented 8 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on XOMA, XOMA Corp at 24-Feb-2026.
Analyst best performing recommendations are on XOMA (XOMA CORP).
The best stock recommendation documented was for XOMA (XOMA CORP) at 12/11/2025. The price target of $45 was fulfilled within 209 days with a profit of $18.46 (69.56%) receiving and performance score of 3.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Oct-2017
$39
$-1.17 (-2.91%)
$97
5 months 1 days ago
(30-Apr-2026)
1/28 (3.57%)
$-1.94 (-4.74%)
1154
Buy Since 29-Apr-2024
$50
$9.83 (24.47%)
$45
7 months 7 days ago
(24-Feb-2026)
2/4 (50%)
$22.96 (84.91%)
463
Buy Since 09-Sep-2025
$50
$9.83 (24.47%)
$35
1 years 22 days ago
(09-Sep-2025)
1/2 (50%)
$13.24 (36.02%)
140
Buy Since 07-Sep-2021
$22
$-18.17 (-45.23%)
$19
5 years 24 days ago
(07-Sep-2021)
5/6 (83.33%)
$-3.26 (-12.91%)
196
Hold Since 10-Mar-2016
10 years 6 months 21 days ago
(10-Mar-2016)
2/2 (100%)
$49.6 (70.45%)
1113
What Year was the first public recommendation made by Jason Zhuang?
